More on Seattle Genetics (SGEN): Q4 beats across the board on a 30% jump in total sales. Bottom...

|About: Seattle Genetics, Inc. (SGEN)|By:, SA News Editor

More on Seattle Genetics (SGEN): Q4 beats across the board on a 30% jump in total sales. Bottom line numbers were boosted by higher Adcetris sales and lower SG&A expenses, but were offset somewhat by higher R&D costs. Shares +0.6% AH.